HI HCR22

Requests the University of Hawaii College of Tropical Agriculture and Human Resources to study developing hemp varieties with increased cannabidiol (CBD) levels while maintaining tetrahydrocannabinol (THC) content below 0.3 percent to comply with the 2018 federal Farm Act.

Notes that the FDA has recognized hemp-derived cannabidiol benefits for treating multiple forms of epilepsy, including Dravet syndrome and Lennox-Gastaut syndrome that are often resistant to anti-seizure medications.

Cites research demonstrating cannabidiol's potential benefits for anxiety, depression, multiple sclerosis, arthritis, inflammation, chronic pain, and other medical conditions.

Requires certified copies of the resolution be sent to the Chairperson of the Board of Agriculture, the President of the University of Hawaii, and the Chairperson of the College of Tropical Agriculture and Human Resources.